ATXS: Astria Therapeutics, Inc. Stock

by  •  • Comments Off on ATXS: Astria Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 513.44
Enterprise Value ($M) 433.23
Book Value ($M) 243.12
Book Value / Share 4.43
Price / Book 2.11
NCAV ($M) 239.39
NCAV / Share 4.36
Price / NCAV 2.14

Profitability (mra)
Return on Invested Capital (ROIC) -0.30
Return on Assets (ROA) -0.33
Return on Equity (ROE) -0.34

Liquidity (mrq)
Quick Ratio 21.73
Current Ratio 21.73

Balance Sheet (mrq) ($M)
Current Assets 250.94
Assets 254.67
Liabilities 11.55
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -67.83
Net Income -72.89
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -68.44
Cash from Investing 135.05
Cash from Financing 88.40

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-11 13G/A Fmr Llc 9.08 -8.83
03-07 13G/A BlackRock Inc. 4.50 12.41
02-14 13G/A Cormorant Asset Management, LP 0.00 -100.00
02-14 13G/A Fairmount Funds Management LLC 9.90 91.12
02-14 13G/A Deep Track Capital, LP 0.00 -100.00
02-13 13G Vanguard Group Inc 5.66
02-13 13G/A Vivo Opportunity, LLC 4.50 47.68
02-12 13G Ra Capital Management, L.p. 8.10
02-05 13D/A Perceptive Advisors Llc 11.90 78.78
01-16 13G TCG Crossover GP II, LLC 9.90
01-02 13G Venrock Healthcare Capital Partners III, L.P. 8.90

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-04 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 40,400 440,569 9.17
2024-05-02 89,981 257,879 34.89
2024-05-01 357,496 598,683 59.71
2024-04-30 41,668 256,050 16.27
2024-04-29 40,898 234,499 17.44

(click for more detail)

Similar Companies
ARCT – Arcturus Therapeutics Holdings Inc. ARDX – Ardelyx, Inc.
ATAI – Atai Life Sciences N.V. AUPH – Aurinia Pharmaceuticals Inc.
AURA – Aura Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io